Covaxin, the Coronavirus vaccine, maker Bharat Biotech on Tuesday said the price of Covaxin supplied to the Indian government at ₹150 per dose is a non-competitive price and is not sustainable in the long run and requires a higher price to offset part of the cost.
Covaxin, the Coronavirus vaccine, maker Bharat Biotech on Tuesday said the price of Covaxin supplied to the Indian government at ₹150 per dose is a non-competitive price and is not sustainable in the long run and requires a higher price to offset part of the cost.